PCMI
ABBV icon

Princeton Capital Management Inc’s AbbVie ABBV Stock Holding History

Princeton Capital Management Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.25M Buy
25,284
+6,038
+31% +$460K 1.14% 31
2017
Q2 		$1.39M Buy
+19,246
New +$1.29M 0.88% 36

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Princeton Capital Management Inc's ABBV Position: Q3 2017 in Review

Princeton Capital Management Inc increased its AbbVie (ABBV) stake by 31% in Q3 2017, buying an estimated $460K and bringing the position to 25,284 shares worth $2.25M. The position accounts for 1.14% of the portfolio, ranked #31.

Princeton Capital Management Inc first reported a position in ABBV in Q2 2017 and has held it in 2 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Princeton Capital Management Inc held 25,284 shares of AbbVie worth $2.25M as of Q3 2017.
  • Princeton Capital Management Inc bought 6,038 AbbVie shares in Q3 2017, an estimated $460K.
  • AbbVie made up 1.14% of Princeton Capital Management Inc's portfolio in Q3 2017, its #31 holding.
  • Princeton Capital Management Inc first reported a position in AbbVie in Q2 2017 and has held it in 2 quarters since.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.